Sulfur - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulfur and what is the scope of freedom to operate?
Sulfur
is the generic ingredient in two branded drugs marketed by Poythress and Bracco, and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for sulfur.
Summary for sulfur
US Patents: | 3 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 77 |
Patent Applications: | 33 |
Formulation / Manufacturing: | see details |
DailyMed Link: | sulfur at DailyMed |
Recent Clinical Trials for sulfur
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Societa Italiana di Chirurgia ColoRettale | N/A |
Neopharmed Gentili S.p.A. | N/A |
University of Wisconsin, Madison | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for sulfur
US Patents and Regulatory Information for sulfur
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Poythress | BENSULFOID | sulfur | POWDER;TOPICAL | 002918-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |